Singapore markets close in 2 hours 46 minutes

TherapeuticsMD, Inc. (TXMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.1400+0.0500 (+2.39%)
At close: 04:00PM EDT
2.1700 +0.03 (+1.40%)
After hours: 07:35PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
68,307
111,997
-172,415
-183,524
-176,145
Depreciation & amortisation
594
1,200
736
4,067
1,392
Stock-based compensation
4,140
11,572
18,125
10,679
10,682
Change in working capital
-35,129
-4,086
4,591
-3,341
-14,032
Accounts receivable
-
-
-4,327
-8,224
-13,651
Inventory
-
-
-711
-3,337
-8,593
Accounts payable
-1,387
-1,211
-1,062
1,887
-3,563
Other working capital
-1,396
9,004
-144,916
-161,069
-189,610
Other non-cash items
156
-401
720
11,278
1,930
Net cash provided by operating activities
-1,322
9,359
-142,693
-159,471
-165,718
Cash flows from investing activities
Investments in property, plant and equipment
-
-355
-2,223
-1,598
-23,892
Other investing activities
-20.42
-
-
-
-20.42
Net cash used for investing activities
223,760
-355
-2,223
-1,598
-23,892
Cash flows from financing activities
Debt repayment
-94,432
-219,432
-50,000
0
-81,661
Common stock issued
1,163
2,468
184,348
31,703
77,031
Common stock repurchased
-
-38,657
0
-
-
Other financing activities
-
-1,269
-5,118
-1,250
-6,652
Net cash used provided by (used for) financing activities
-110,796
-235,206
129,552
80,725
188,827
Net change in cash
-28,164
-15,805
-15,364
-80,344
-783
Cash at beginning of period
38,330
65,122
80,486
160,830
161,613
Cash at end of period
10,166
49,317
65,122
80,486
160,830
Free cash flow
Operating cash flow
-1,322
9,359
-142,693
-159,471
-165,718
Capital expenditure
-
-355
-2,223
-1,598
-23,892
Free cash flow
-1,396
9,004
-144,916
-161,069
-189,610